Innovative Joint Repair Solutions by Smith+Nephew at AAOS 2025

Introducing Smith+Nephew’s Cutting-Edge Sports Medicine Technologies
Smith+Nephew (LSE:SN, NYSE:SNN), a leader in global medical technology, has announced an exciting showcase of its latest innovations in Sports Medicine, particularly dedicated to joint repair, at the upcoming American Academy of Orthopaedic Surgeons Annual Meeting. This year's event, held in San Diego, is an excellent opportunity for practitioners to engage with pioneering technologies that are set to transform clinical practice.
Innovative Spatial Surgery Technology
Revolutionizing Arthroscopic Surgery
One of the flagship technologies that will be presented is the concept of Spatial Surgery. Smith+Nephew is proud to unveil the TESSA System (Tracking Enabled Spatial Surgery Assistant), which is currently under 510(k) review. This innovative tool is designed to enhance arthroscopic surgical procedures by incorporating real-time tracking and advanced imaging techniques. Surgeons using TESSA will benefit from augmented reality guidance, facilitating better decision-making during operations. This level of personalization in operative planning is expected to significantly improve surgical outcomes.
CARTIHEAL AGILI-C Cartilage Repair Implant
Transformative Cartilage Treatment Options
Another cornerstone of Smith+Nephew’s offerings is the CARTIHEAL AGILI-C Cartilage Repair Implant, recognized for its groundbreaking capabilities in cartilage repair. Previously awarded breakthrough designation by the FDA, this device enables surgeries for patients who previously had limited options for cartilage restoration. In a pivotal clinical trial, those treated with the AGILI-C implant showcased remarkable improvements in knee function and mobility over four years, vastly outperforming traditional surgical methods.
- Clinical Excellence: Patients using the CARTIHEAL AGILI-C saw dramatic improvements in knee function and pain management over the treatment period.
- Lower Risk of Further Procedures: The implant has been associated with a significantly reduced need for additional surgeries like total knee arthroplasty (TKA) or osteotomy.
- Diverse Patient Suitability: The AGILI-C scaffold effectively addresses a wide range of patient profiles, demonstrating versatile results across age groups and those with osteoarthritis.
The application of the CARTIHEAL implant will be elaborated during a special presentation at AAOS, highlighting its value in treating patients with osteoarthritis. The presentation is set for March 12, and practitioners are encouraged to attend.
REGENETEN Bioinductive Implant for Tendon Repair
Advancing Tendon Injury Treatments
For over a decade, Smith+Nephew’s REGENETEN Bioinductive Implant has set a new standard for treating tendon injuries, primarily focusing on rotator cuff repairs. This implant is made from highly purified type I collagen fibers, presenting an advanced option for surgeons. Clinical evidence supports its superiority, with significant reductions in re-tear risks and faster recovery times when compared with traditional repair methods.
- Significant Risk Reduction: The REGENETEN implant reduces the chances of re-tear by three times in certain surgical trials.
- Speedy Recovery: Patients recover faster and can return to their normal activities more quickly when treated with this innovative solution.
- Proven Track Record: With usage in over 150,000 procedures, the REGENETEN implant benefits from a highly efficient delivery system that minimizes operative time.
Beyond its success in traditional locations, the use of the REGENETEN implant is increasingly recognized among surgeons for its potential in various tendons, including those in the hip, knee, and ankle, marking its versatility across multiple anatomical areas.
Visit Smith+Nephew at AAOS
Smith+Nephew invites attendees to explore its full range of Sports Medicine joint repair solutions and technologies at booth #3729 during the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego from March 11-13, 2025. For more details about the company and its offerings, please visit www.smith-nephew.com.
Frequently Asked Questions
What is the main focus of the Smith+Nephew showcase at AAOS 2025?
The showcase primarily highlights advancements in Sports Medicine, specifically innovations in joint repair technologies.
What is the TESSA System?
The TESSA System is a Tracking Enabled Spatial Surgery Assistant designed to enhance arthroscopic surgeries through real-time tracking and augmented reality.
How does the CARTIHEAL AGILI-C Cartilage Repair Implant benefit patients?
It provides a surgical option for cartilage repair, showing significant improvement in knee functionality and lower risks of additional surgeries.
What is the purpose of the REGENETEN Bioinductive Implant?
The REGENETEN implant is used to treat tendon injuries, particularly in rotator cuff repairs, and is known for its low re-tear rates and quicker patient recovery.
How can I learn more about Smith+Nephew’s offerings?
You can visit Smith+Nephew's booth at AAOS or check their website for detailed information about their innovative medical technologies.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.